<i>Flavobacterium</i> IR1中<i>moe</i>A基因的缺失导致结构颜色由绿转蓝并改变多糖代谢
Deletion of the moeA gene in Flavobacterium IR1 drives structural color shift from green to blue and alters polysaccharide metabolism
生物技术与制药领域的最新动态
Deletion of the moeA gene in Flavobacterium IR1 drives structural color shift from green to blue and alters polysaccharide metabolism
Differential destinations, dynamics, and functions of high- and low-order features in the feedback signal during object processing
AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
FOCAS: Transcriptome-wide screening of individual m6A sites functionally dissects epitranscriptomic control of gene expression in cancer
Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi
Magical thinking will not prevent future pandemics or improve public health | Science
Genomic and morphometric evidence for Austronesian-mediated pig translocation in the Pacific | Science
SPARK-seq: A high-throughput platform for aptamer discovery and kinetic profiling | Science
De novo design of small molecule–regulated protein oligomers | Science
Limiting phosphonic acid interlayer–perovskite reactivity to stabilize perovskite solar modules | Science
Ninety One UK Ltd Purchases 29,806 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
273,111 Shares in Illumina, Inc. $ILMN Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Fenimore Asset Management Inc Acquires 405,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Quanterix's blood test for Alzheimer's disease uncovers potentially treatable population in decades-long study
Thermo Fisher: Refinding Some Momentum (NYSE:TMO) - Seeking Alpha
Vanda stock jumps with FDA approval of motion sickness drug
Corcept looks to ovarian cancer as relacorilant gets CRL in Cushing
Blossomhill advancing EGFR, CLK inhibitors with series B extension
Axsome’s Auvelity for Alzheimer’s agitation gets priority review
AbbVie does T cell engager deal in China for Zelgen's DLL3-targeted drug